Press Releases
Catalent Launches OneXpress Solution to Accelerate Oral Dosage Products from Clinic to Launch
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced the launch of its new OneXpress™ service for the integrated development, scale up and...
Drug Research
Syngene joins global industry consortium to accelerate collaborative research in COVID-19 testing
Syngene International Limited announced that it has joined a global consortium of 19 organizations from the healthcare industry, led by Bristol Myers Squibb, to help inform, improve and accelerate various aspects of COVID-19 testing, ranging from research to clinical...
Clinical Trials
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
FSD Pharma Inc. announced that the U.S. FDA has authorized the initiation of a Phase 2 study for the use of FSD201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID-19, the disease caused by the SARS-CoV-2 virus (the “FSD201...
IT & Data Management
AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence
Belgium-based AARDEX Group, the world leader in medication adherence solutions, announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devices. The alliance will further extend the comprehensive portfolio of...
Press Releases
Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation
FUJIFILM Corporation announces the conclusion of a manufacturing contract agreement with biotechnology company, VLP Therapeutics Japan LLC (Representative Executor: Wataru Akahata, hereinafter “VLP Therapeutics”) regarding COVID-19 vaccine formulation developed by VLP Therapeutics.
VLP Therapeutics' COVID-19 vaccine is self-amplifying (replicon) RNA*...
Drug Research
Regenerons REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients
Regeneron Pharmaceuticals, Inc. announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19....
Packaging & Labelling
Aptar Pharma to Unveil its State-of-the-Art Virtual Booth at CPhI Festival of Pharma
Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, is pleased to announce its Platinum Sponsorship of the CPhI Festival of Pharma, to be held online from October 5-16, 2020. A long-time strategic partner...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















